申请人:G. D. Searle & Company
公开号:US05635514A1
公开(公告)日:1997-06-03
Compounds of the formula: ##STR1## and the pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising a therapeutically-effective amount of the compounds or salts in combination with a pharmaceutically-acceptable carrier and methods for treating 5-lipoxygenase mediated conditions, inflammation-associated disorders and allergies.
该式化合物及其药用可接受的盐,包含该化合物或盐的治疗有效量与药用可接受载体结合的药物组合物,以及治疗5-脂氧合酶介导的疾病、与炎症相关的疾病和过敏症的方法。